Impact of body surface area on efficacy and safety in patients with EGFR-mutant non-small cell lung cancer treated with osimertinib as a first-line treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of body surface area on efficacy and safety in patients with EGFR-mutant non-small cell lung cancer treated with osimertinib as a first-line treatment

Published:2024 Issue: Volume:40 Page:100836
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Tanaka Saki,Tamiya Motohiro,Nishiuma Satoshi,Nakamura Sayaka,Nozaki Keisuke,Watanabe Naoko,Itoh Chisae,Kadokawa Yukio,Takeda Kenji,Takahashi Kozo,Miyazaki Akito,Kawamura Takahisa,Kunimasa Kei,Inoue Takako,Nishino Kazumi,Takagi Mari

Publisher

Elsevier BV

Reference20 articles.

1. Cancer statistics;Siegel;CA. Cancer J. Clin.,2021

2. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N. Engl. J. Med.,2004

3. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

4. Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes;Drilon;Nat. Rev. Clin. Oncol.,2018

5. Targeted therapies for lung cancer patients with oncogenic driver molecular alterations;Tan;J. Clin. Oncol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP